JUL 22, 2019 2:39 PM PDT

New Freezing Technique for Breast Cancer Patients in Low Income Countries

WRITTEN BY: Julia Travers

Treatment for breast cancer can be too expensive and hard to access for many women in lower-income countries. These women are disproportionately affected by breast cancer and experience a higher related mortality rate. In the United States, more than 90 percent of women survive breast cancer. But in countries like The Gambia, Saudi Arabia or Uganda, survival rates are much lower, ranging from about 12 to 64 percent.

A student-led research team of the Biomedical Engineering Design Program at Johns Hopkins University is creating a novel approach to bringing successful treatment to more breast cancer patients around the world. Many of these women cannot afford or reach procedures like chemotherapy, radiation and surgery. Cryoablation, or killing cancerous tissue by freezing it, can be preferable because it does not require an operating room or anesthesia and so can be performed in community clinics.

This technique typically uses argon gas, which can cost as much as $10,000 per treatment and can be hard to come by in many parts of the world. The Johns Hopkins team used carbon dioxide instead, which is much cheaper and easier to find. According to EurekAlert, they tested this procedure in three experiments that mimicked the temperatures and conditions of human breasts, finding it could successfully kill tumor tissue. The three test materials or environments were ultrasound gel, rats with mammary tumors and the normal liver of a pig. The device met standard freezing temperatures for tissue death for similar U.S. devices and killed at least 85 percent of the tumor tissue.

"Innovation in cancer care doesn't always mean you have to create an entirely new treatment, sometimes it means radically innovating on proven therapies such that they're redesigned to be accessible to the majority of the world's population," Bailey Surtees, the study's first author and a Johns Hopkins University biomedical engineering graduate, said. The researchers now plan to continue testing the device for use with people and also hope to broaden its application to pets. Their findings were published in July 2019 in PLOS One.

 

An animation of the procedure is below:

 

 

Source: EurekAlert

 
About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
MAR 28, 2020
Cancer
MAR 28, 2020
The Not So Minor Genetic Players in Head and Neck Cancers
Head and neck squamous cell carcinomas (HNSCC) are among the most prevalent cancers among smokers, linked to alcohol con ...
APR 16, 2020
Cancer
APR 16, 2020
The Unseen Barriers Surrounding Pancreatic Cancer
Pancreatic cancer is one of the deadliest cancers in the world. With a poor five year prognosis and lack of effective tr ...
APR 20, 2020
Cancer
APR 20, 2020
Expanding the Diagnostic Toolkit in Cancer Research with isomiRNAs
Esophageal cancers are one of the more common cancers around the world, with an unfortunately poor prognosis. The five-y ...
APR 23, 2020
Cancer
APR 23, 2020
Dual Inhibition from One Chemotherapy
Acute Myeloid Leukemia, or AML, is an aggressive blood cancer with a poor 5-year prognosis. The primary targets of chemo ...
APR 25, 2020
Cancer
APR 25, 2020
Breaking the Blood-Brain Barrier in the Fight Against Brain Cancer
One of the more unique aspects of the human body is the blood-brain barrier (BBB) that protects the central nervous syst ...
MAY 18, 2020
Cancer
MAY 18, 2020
The threat of climate change extends to cancer progression
A study appearing in the American Cancer Society’s CA: A Cancer Journal for Clinicians argues that climate change ...
Loading Comments...